A
C
G
U
A
C
G
U
A
C
G
U
A
A
G
U
A
C
G
A
A
C
G
A
A
C
G
U
A
A
A
U
A
C
G
U
A
C
G
U
A
C
A
U
A
C
G
U
A
C
G
A
A
A
G
U
A
C
G
U
A
A
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
A
G
U
A
C
G
U
A
C
G
U
A
C
G
A
A
C
G
U
A
C
A
U
A
C
G
U
A
A
G
A
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
A
G
U
A
C
G
A
A
C
G
U
A
C
G
U
A
C
G
U
A
A
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
A
A
A
C
A
U
A
C
G
U
A
C
G
A
A
A
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
A
A
C
G
U
A
C
G
U
A
C
G
A
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
A
U
A
C
A
U
A
C
G
U
A
C
G
U
A
C
G
A
A
A
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
A
A
C
G
U
A
C
G
U
A
C
A
A
A
C
G
U
A
A
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
A
A
C
G
U
A
C
G
A
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
A
A
C
G
U
A
C
A
U
A
C
A
U
A
A
G
U
A
C
G
A
A
C
G
A
A
C
A
U
A
C
G
A
A
A
G
U
A
C
A
U
A
C
G
U
A
C
G
U
A
C
A
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
A
A
A
G
U
A
C
G
U
A
C
A
U
A
A
G
U
A
A
G
A
A
C
G
U
A
C
A
U
A
C
A
U
A
C
G
U
A
C
G
U
A
C
G
U
A
A
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
A
A
C
G
U
A
C
G
U
A
C
G
U
A
C
A
U
A
C
G
U
A
C
A
U
A
C
G
U
A
C
G
A
A
C
G
U
A
A
G
U
A
C
A
U
A
A
G
U
A
C
G
U
A
C
G
U
A
C
A
U
A
C
G
U
A
C
A
U
A
C
G
U
A
A
G
U
A
C
A
U
A
A
G
A
A
C
A
U
A
A
A
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
A
G
U
A
C
G
U
A
C
G
U
A
C
G
A
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
A
G
U
A
C
A
A
A
C
G
A
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
A
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
A
G
U
A
A
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
G
U
A
A
A
U
A
C
G
U
A
C
G
U
A
C
G
U
A
C
A
U
A
C
A
U
A
A
G
U
A
C
G
U
A
A
G
A
A
C
A
U
A
A
G
U
A
C
G
U
A
A
A
U
A
C
G
U
A
C
A
A
A
C
G
U
A
C
G
U
A
C
A
U
A
C
G
U
A
C
G
U
A
A
G
U
A
C
G
U
A
A
G
U
A
C
G
U
A
C

Better genetic medicines,
builtwith AI.

Kerna Labs is unlocking the full potential of mRNA as the universal toolkit for genetic medicine.

A Foundation Model for mRNA Therapeutics

We leverage AI and high-throughput biology to decode RNA biology.

Expression Curve Tuning

Expression Curve Tuning

Customizable expression profiles for diverse therapeutic applications.

Cell-Type Specific Expression

Cell-Type Specific Expression

Precision-targeted delivery for cell-specific therapeutic effects.

Enhanced Half-life

Enhanced Half-life

Prolonged efficacy window through optimized mRNA stability.

Our platform designs mRNA sequences that drive magnitude higher protein output with unprecedented cell-type precision.

Built by the leading minds in machine learning and RNA

Amit Deshwar, PhD profile

Amit Deshwar, PhD

Co-founder & CTO

Deep Genomics
Google
University of Toronto
Melissa J. Moore, PhD profile

Melissa J. Moore, PhD

Co-founder

RNA Therapeutics Institute
UMass Medical
Moderna
National Academy of Sciences
Tessera
nChroma
Julia Peng profile

Julia Peng

Co-founder & CEO

Wharton
Confluent
JP Morgan
Michael Swift, PhD profile

Michael Swift, PhD

Founding Scientist

Stanford
Longitude Capital
miRagen
Oliver Chang, PhD profile

Oliver Chang, PhD

Platform Scientist

Princeton
ODBI
Nitin Raj, PhD profile

Nitin Raj, PhD

Principal Scientist

Inceptive
Stanford Medicine
Aryan Misra profile

Aryan Misra

Machine Learning

University of Toronto
Declan Coleman profile

Declan Coleman

Research Associate

Ponoma College
Bullseye Bio

Advised by the top scientific minds in genetic medicine

Catherine Stehman-Breen, MD profile

Catherine Stehman-Breen, MD

Advisor

nChroma
Dyne Therapeutics
Amgen
Regeneron
Sarepta Therapeutics
Jacob Kimmel, PhD profile

Jacob Kimmel, PhD

Advisor

NewLimit
Calico Life Sciences
UCSF
Kerry Benenato, PhD profile

Kerry Benenato, PhD

Advisor

AstraZeneca
Moderna
76Bio
Sail Biomedicines
Michael Czech, PhD profile

Michael Czech, PhD

Advisor

HHMI
UMass Medical
Silvia Corvera, MD profile

Silvia Corvera, MD

Advisor

University of Pennsylvania
UMass Medical

Built by a world-class team

Cell
Nature
Science
PNAS
CSH

Backed by visionary partners

Gradient Ventures
Humba Ventures
Tau Ventures
Pioneer Fund
Xeia Venture Partners

Media & Publications

Pioneering the next era of genetic medicine.

We are building large-scale machine learning models to design mRNA with unmatched potency, targeting, and safety.

News

April 2, 2025

Melissa Moore to speak at ASBMB 2025

News

January 15, 2025

AI-designed mRNA therapies: A universal toolkit for genetic medicine

News

January 13, 2025

Ex-Deep Genomics, Moderna execs get backing, led by Gradient to develop next-generation mRNA therapeutics with AI

News

January 10, 2025

Exclusive: Moderna's former top scientist has a new startup using AI to improve mRNA therapies

Connect With Us

Learn more about how we're enabling our partners in their mRNA pipeline development.

Contact Us